CME Group and FTSE Russell have renewed their exclusive licensing agreement for index-based derivatives for a further 12 years, extending their partnership until 2037.
This extension allows CME Group to continue offering futures, futures options and over-the-counter cleared products based on the FTSE Russell indices, including the Russell 1000, Russell 2000, FTSE Developed Europe and FTSE China 50.
“We are very pleased to extend our licensing agreement and partnership with FTSE Russell,” said Tim McCourt, global head of equities, FX and alternatives products at CME Group.
“Our FTSE Russell futures and options have grown significantly over our decades-long partnership, providing clients with deep liquidity and the potential for greater capital efficiency when they trade across our equity pool.”
Fiona Bassett, CEO of FTSE Russell, said: “The continued growth in trading volumes across FTSE Russell-linked products reflects the strength of our indices and the value they provide to investors looking to measure performance across the global equity market.”
Since its last renewal in 2015, more than 573 million contracts linked to the FTSE Russell Index have been traded on the CME Group.
The exchange reported an average daily volume of 306,000 contracts this year across futures and Russell options, underscoring strong demand from investors for transparent and efficient index-based exposure.